JHTAX has more cash in the bank: 3.29B vs. FEQDX (767M). JHTAX pays higher dividends than FEQDX: JHTAX (0.29) vs FEQDX (0.00). FEQDX was incepted earlier than JHTAX: FEQDX (4 years) vs JHTAX (5 years). FEQDX (1.58) is less costly to investors than JHTAX (0.84). FEQDX is a more actively managed with annual turnover of: 107.00 vs. JHTAX (44.00). FEQDX has a lower initial minimum investment than JHTAX: FEQDX (0) vs JHTAX (1000). FEQDX annual gain was more profitable for investors over the last year : 13.86 vs. JHTAX (10.11).

	FEQDX	JHTAX	FEQDX / JHTAX
Total Expense Ratio	1.55	0.84	185%
Annual Report Gross Expense Ratio	1.58	0.84	188%
Fund Existence	4 years	5 years	-
Gain YTD	8.906	5.090	175%
Front Load	N/A	5%	-
Min. Initial Investment	0	1000	-
Min. Initial Investment IRA	N/A	N/A	-
Net Assets	767M	3.29B	23%
Annual Yield % from dividends	0.00	0.29	-
Returns for 1 year	13.86	10.11	137%
Returns for 3 years	55.79	41.64	134%
Returns for 5 years	N/A	38.52	-
Returns for 10 years	N/A	N/A	-

View a ticker or compare two or three

Ask AI

Compare

Interact to see
Advertisement

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
NTLA	13.28	1.68	+14.48%
Intellia Therapeutics
KPTI	2.00	0.07	+3.63%
Karyopharm Therapeutics Inc.
ESTC	87.34	2.33	+2.74%
Elastic NV
GSRFU	10.36	N/A	N/A
GSR IV Acquisition Corp.
STRO	21.91	-0.13	-0.59%
Sutro Biopharma Inc.